Cargando…
Systematic review: non-adherence and non-persistence in intravitreal treatment
PURPOSE: Intravitreal injection of VEGF inhibitors has become the standard of care for different macular diseases within the last years resulting in improved visual outcomes. Under real-life conditions, however, the necessity for frequent retreatments and reexaminations poses a burden for patients a...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7550304/ https://www.ncbi.nlm.nih.gov/pubmed/32572607 http://dx.doi.org/10.1007/s00417-020-04798-2 |
_version_ | 1783592947257704448 |
---|---|
author | Ehlken, Christoph Ziemssen, Focke Eter, Nicole Lanzl, Ines Kaymak, Hakan Lommatzsch, Albrecht Schuster, Alexander K. |
author_facet | Ehlken, Christoph Ziemssen, Focke Eter, Nicole Lanzl, Ines Kaymak, Hakan Lommatzsch, Albrecht Schuster, Alexander K. |
author_sort | Ehlken, Christoph |
collection | PubMed |
description | PURPOSE: Intravitreal injection of VEGF inhibitors has become the standard of care for different macular diseases within the last years resulting in improved visual outcomes. Under real-life conditions, however, the necessity for frequent retreatments and reexaminations poses a burden for patients and treatment centers. Non-adherence and non-persistence to intravitreal treatment may lead to inferior clinical outcomes, and knowledge of contributing factors is crucial to improve adherence. This systematic review analyzes current literature for potential factors involved in non-adherence and non-persistence. METHODS: A systematic search was conducted in PubMed and Embase including three different aspects of intravitreal injection therapy: (1) diseases with intravitreal injections as treatment, (2) intravitreal injection, and (3) aspects of therapy adherence or therapy persistence. Data from identified quantitative studies were further extracted and grouped according to WHO criteria (condition, socio-economy, therapy, patient, and health system). The methodological quality of identified studies was graded. Identified qualitative studies (i.e., interviews) were descriptively analyzed and their findings narratively reported. RESULTS: Twenty-four publications were included. In 16 of those publications, a quantitative data analysis was conducted, analyzing factors associated with non-adherence. Worse visual acuity at baseline and unfavorable development of visual acuity, higher age, and greater distance to the treatment center were associated with non-adherence, while there was inconsistent evidence for an association of comorbidity. In qualitative studies, high follow-up/treatment burden, fear and anxiety, disappointed patient expectations, and lack of motivation to continue treatment were reported as reasons for non-persistence. CONCLUSIONS: Knowledge of potential barriers in IVT treatment may improve adherence and potentially clinical results. Improvements can be achieved particularly in the healthcare complex (organizational improvements) and the “patient” complex by establishing realistic expectations. Recurrent education of the patient may be necessary. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00417-020-04798-2) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-7550304 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-75503042020-10-19 Systematic review: non-adherence and non-persistence in intravitreal treatment Ehlken, Christoph Ziemssen, Focke Eter, Nicole Lanzl, Ines Kaymak, Hakan Lommatzsch, Albrecht Schuster, Alexander K. Graefes Arch Clin Exp Ophthalmol Review Article PURPOSE: Intravitreal injection of VEGF inhibitors has become the standard of care for different macular diseases within the last years resulting in improved visual outcomes. Under real-life conditions, however, the necessity for frequent retreatments and reexaminations poses a burden for patients and treatment centers. Non-adherence and non-persistence to intravitreal treatment may lead to inferior clinical outcomes, and knowledge of contributing factors is crucial to improve adherence. This systematic review analyzes current literature for potential factors involved in non-adherence and non-persistence. METHODS: A systematic search was conducted in PubMed and Embase including three different aspects of intravitreal injection therapy: (1) diseases with intravitreal injections as treatment, (2) intravitreal injection, and (3) aspects of therapy adherence or therapy persistence. Data from identified quantitative studies were further extracted and grouped according to WHO criteria (condition, socio-economy, therapy, patient, and health system). The methodological quality of identified studies was graded. Identified qualitative studies (i.e., interviews) were descriptively analyzed and their findings narratively reported. RESULTS: Twenty-four publications were included. In 16 of those publications, a quantitative data analysis was conducted, analyzing factors associated with non-adherence. Worse visual acuity at baseline and unfavorable development of visual acuity, higher age, and greater distance to the treatment center were associated with non-adherence, while there was inconsistent evidence for an association of comorbidity. In qualitative studies, high follow-up/treatment burden, fear and anxiety, disappointed patient expectations, and lack of motivation to continue treatment were reported as reasons for non-persistence. CONCLUSIONS: Knowledge of potential barriers in IVT treatment may improve adherence and potentially clinical results. Improvements can be achieved particularly in the healthcare complex (organizational improvements) and the “patient” complex by establishing realistic expectations. Recurrent education of the patient may be necessary. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00417-020-04798-2) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2020-06-22 2020 /pmc/articles/PMC7550304/ /pubmed/32572607 http://dx.doi.org/10.1007/s00417-020-04798-2 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Review Article Ehlken, Christoph Ziemssen, Focke Eter, Nicole Lanzl, Ines Kaymak, Hakan Lommatzsch, Albrecht Schuster, Alexander K. Systematic review: non-adherence and non-persistence in intravitreal treatment |
title | Systematic review: non-adherence and non-persistence in intravitreal treatment |
title_full | Systematic review: non-adherence and non-persistence in intravitreal treatment |
title_fullStr | Systematic review: non-adherence and non-persistence in intravitreal treatment |
title_full_unstemmed | Systematic review: non-adherence and non-persistence in intravitreal treatment |
title_short | Systematic review: non-adherence and non-persistence in intravitreal treatment |
title_sort | systematic review: non-adherence and non-persistence in intravitreal treatment |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7550304/ https://www.ncbi.nlm.nih.gov/pubmed/32572607 http://dx.doi.org/10.1007/s00417-020-04798-2 |
work_keys_str_mv | AT ehlkenchristoph systematicreviewnonadherenceandnonpersistenceinintravitrealtreatment AT ziemssenfocke systematicreviewnonadherenceandnonpersistenceinintravitrealtreatment AT eternicole systematicreviewnonadherenceandnonpersistenceinintravitrealtreatment AT lanzlines systematicreviewnonadherenceandnonpersistenceinintravitrealtreatment AT kaymakhakan systematicreviewnonadherenceandnonpersistenceinintravitrealtreatment AT lommatzschalbrecht systematicreviewnonadherenceandnonpersistenceinintravitrealtreatment AT schusteralexanderk systematicreviewnonadherenceandnonpersistenceinintravitrealtreatment |